Adam Stone
Signal active
Chief Investment Officer
Bio
In 2006 Adam Stone joined Perceptive. Prior to Perceptive he was a senior analyst at Ursus Capital. During his five years there Adam focused on biotech and specialty pharmaceuticals. Adam graduated, with honors, from Princeton University with a B.A. in molecular biology.
Location
New York, New York, United States, North America
Social
Primary Organization
Perceptive Advisors
Founded
1999
Investment
277
Lead investment
95
Exits
144
Employees
11-50
Industry
Financial Services, Venture Capital, Finance
Jobs history
3
Director
2017 - 2022
Prometheus Biosciences
Board of Directors
2020 - Current
Prometheus Biosciences
Board Member
2020 - Current
Board and Advisor Roles
0
N/A
Invest in regions
Profile Resume
Adam Stone is the Chief Investment Officer at Perceptive Advisors, based in New York, New York, United States, North America. With a background in Financial Services, Adam Stone has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
Matt Mickiewicz
Co-Founder
Zander Lurie
CEO
Phil Deutch
Founder & CEO
Quincy Jones
Founder and CEO
Robert Goldberg
Founder & CEO
Investment portfolio
Adam Stone has made 1 investments. Their Latest investment was Series B - Lyte on Dec 17, 2020
Number of investment
1
Number of exits
0
Personal investment
1
| Annouced Date | Organization Name | Funding Round | Money Raised |
|---|---|---|---|
| Dec 17, 2020 | Lyte | Series B - Lyte | 33.0M |
Partner investment
4
| Annouced Date | Organization Name | Funding Round | Investor Name | Money Raised |
|---|---|---|---|---|
| Apr 01, 2019 | - | Series B - SpringWorks Therapeutics | Perceptive Advisors | 125.0M |
| Jun 16, 2020 | C4 Therapeutics | Series B - C4 Therapeutics | Perceptive Advisors | 0 |
| Jun 16, 2020 | C4 Therapeutics | Debt Financing - C4 Therapeutics | Perceptive Advisors | 20.0M |
| Nov 09, 2020 | Prometheus Biosciences | Private Equity Round - Prometheus Biosciences | Perceptive Advisors | 130.0M |
Exits
0
There is no exit available on this Profile
Invest in industries
Recent Activity
There is no recent news or activity for this profile.